Participants in Wegovy clinical trials were more likely to report “severe gastrointestinal adverse reactions,” the FDA's ...
A litter of puppies became ill after eating the mix, a customer told the Virginia Department of Agriculture and Consumer ...
Pacira BioSciences PCRX announced the reception of the ‘940 patent from the U.S. Patent and Trademark Office that protects ...
Intra-Cellular submits an sNDA to the FDA, seeking the label expansion of Caplyta to treat MDD in adults as an adjunctive ...
Discover a study that examined the efficacy and safety of pemafibrate in 360 patients with MASLD and hypertriglyceridaemia.
The USDA’s Food Safety and Inspection Service (FSIS) and the FDA jointly have broad jurisdiction and oversight over the U.S.
About one-third of US adults without diabetes who are eligible for weight loss treatment with GLP-1 receptor agonists and GLP-1/GIP receptor agonists meet exclusion criteria for clinical trials.
Drugmaker Eli Lilly is claiming victory in the battle of weight loss drugs, now one of the most competitive and lucrative ...
SURMOUNT-5’s results reflect those of multiple real-world studies, which have found that tirzepatide treatment results in ...
FDA, industry advocate for standard 'Best if Used By' date labels to reduce consumer confusion about food safety that could ...
Are you confused by food label terms like “Sell By,” “Use By” and “Best By?” If so, you aren’t alone. Federal regulators ...
Marty Makary is a surgeon, prolific author, and avowed contrarian. He’s not a kook but is reckless with the facts, draws ...